BAFF AND APRIL: a tutorial on B cell survival. [Annu Rev Immunol. 2003] - PubMed

loading

Review BAFF and the regulation of B cell survival. [Immunol Lett. 2003]
Review BAFF and the regulation of B cell survival.
Schneider P, Tschopp J. Immunol Lett. 2003 Jul 3; 88(1):57-62.
Novel function of TNF cytokines in regulating bone marrow B cell survival. [Cell Mol Immunol. 2004]
Novel function of TNF cytokines in regulating bone marrow B cell survival.
Zhang M, Ko KH, Lam QL, Lo CK, Xu DJ, Shen L, Zheng B, Srivastava G, Lu L. Cell Mol Immunol. 2004 Dec; 1(6):447-53.
Review The TNF family members BAFF and APRIL: the growing complexity. [Cytokine Growth Factor Rev. 2003]
Review The TNF family members BAFF and APRIL: the growing complexity.
Mackay F, Ambrose C. Cytokine Growth Factor Rev. 2003 Jun-Aug; 14(3-4):311-24.
TACI and BAFF-R mediate isotype switching in B cells. [J Exp Med. 2005]
TACI and BAFF-R mediate isotype switching in B cells.
Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam KP, Bram RJ, Jabara H, Geha RS. J Exp Med. 2005 Jan 3; 201(1):35-9.
BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. [Immunity. 2002]
BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.
Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM, Grewal IS, Cochran AG, Gordon NC, Yin J, et al. Immunity. 2002 Oct; 17(4):515-24.

MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen. [Am J Blood Res. 2013]
MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen.
Fiedler K, Kokai E, Bresch S, Brunner C. Am J Blood Res. 2013; 3(2):124-40. Epub 2013 May 5.
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges. [Ther Adv Neurol Disord. 2013]
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.
Lehmann-Horn K, Kronsbein HC, Weber MS. Ther Adv Neurol Disord. 2013 May; 6(3):161-73.
TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes. [J Allergy Clin Immunol. 2013]
TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
Martinez-Gallo M, Radigan L, Almejún MB, Martínez-Pomar N, Matamoros N, Cunningham-Rundles C. J Allergy Clin Immunol. 2013 Feb; 131(2):468-76. Epub 2012 Dec 11.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

BAFF AND APRIL: a tutorial on B cell survival.
BAFF AND APRIL: a tutorial on B cell survival.
Annu Rev Immunol. 2003 ;21:231-64. Epub 2001 Dec 19 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed